Desuden kan personer, som reagerede med trombocytopeni efter den 1. dosis M- M- RVAXPRO (eller dens komponentvacciner) udvikle trombocytopeni ved yderligere doser.
In addition, individuals who experienced thrombocytopenia with the first dose of M-M-RVAXPRO (or its component vaccines) may develop thrombocytopenia with repeat doses.